Literature DB >> 15978330

Increased expression of mRNA specific for thymidine kinase, deoxycytidine kinase or thymidine phosphorylase in human papillary thyroid carcinoma.

Malgorzata Karbownik1, Ewa Brzezianska, Andrzej Lewinski.   

Abstract

The aim of the present study was to estimate the expression of mRNA, specific for thymidine kinase 1 (TK1), deoxycytidine kinase (dCK), and thymidine phosphorylase (dThdPase), i.e. enzymes involved in pyrimidine and purine metabolism in human papillary thyroid carcinoma (PTC) tissue. Additionally, the expression of dCK was estimated, in medullary thyroid carcinoma (MTC). For control, the RNA expression levels for all the enzymes were measured in macroscopically unchanged thyroid tissue. Reverse transcriptase-polymerase chain reaction (RT-PCR) and densitometry were employed for mRNA expression measurements, with the beta-actin gene as a control housekeeping gene. The levels of mRNA expression for TK1, dCK and dThdPase in human PTC, as well as mRNA expression for dCK in MTC, were significantly higher than mRNA expressions for those enzymes found in macroscopically unchanged thyroid tissue. It is concluded that an increased expression of mRNA, specific for TK1, dCK and dThdPase, may be involved in carcinogenic processes in the human thyroid.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15978330     DOI: 10.1016/j.canlet.2004.10.044

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer.

Authors:  Bo Qiu; Ling-Yu Chu; Xin-Xin Li; Yu-Hui Peng; Yi-Wei Xu; Jian-Jun Xie; Xiao-Yang Chen
Journal:  Onco Targets Ther       Date:  2020-11-24       Impact factor: 4.147

2.  Knockdown of Thymidine Kinase 1 Suppresses Cell Proliferation, Invasion, Migration, and Epithelial-Mesenchymal Transition in Thyroid Carcinoma Cells.

Authors:  Chang Liu; Jian Wang; Li Zhao; Hui He; Pan Zhao; Zheng Peng; Feiyuan Liu; Juan Chen; Weiqing Wu; Guangsuo Wang; Fajin Dong
Journal:  Front Oncol       Date:  2020-01-29       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.